| 000 | 01890 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516141451.0 | ||
| 264 | 0 | _c20131029 | |
| 008 | 201310s 0 0 eng d | ||
| 022 | _a1791-244X | ||
| 024 | 7 |
_a10.3892/ijmm.2013.1303 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCho, Jae-We | |
| 245 | 0 | 0 |
_aDownregulation of type I collagen expression in silibinin-treated human skin fibroblasts by blocking the activation of Smad2/3-dependent signaling pathways: potential therapeutic use in the chemoprevention of keloids. _h[electronic resource] |
| 260 |
_bInternational journal of molecular medicine _cMay 2013 |
||
| 300 |
_a1148-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 |
_aCell Nucleus _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aChemoprevention |
| 650 | 0 | 4 |
_aCollagen Type I _xgenetics |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKeloid _xdrug therapy |
| 650 | 0 | 4 |
_aMatrix Metalloproteinases _xmetabolism |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSilybin |
| 650 | 0 | 4 |
_aSilymarin _xpharmacology |
| 650 | 0 | 4 |
_aSkin _xpathology |
| 650 | 0 | 4 |
_aSmad Proteins _xmetabolism |
| 650 | 0 | 4 |
_aSmad2 Protein _xmetabolism |
| 650 | 0 | 4 |
_aSmad3 Protein _xmetabolism |
| 650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinase-1 _xmetabolism |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xpharmacology |
| 700 | 1 | _aIl, Kwon-Jun | |
| 700 | 1 | _aLee, Kyu-Suk | |
| 773 | 0 |
_tInternational journal of molecular medicine _gvol. 31 _gno. 5 _gp. 1148-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/ijmm.2013.1303 _zAvailable from publisher's website |
| 999 |
_c22590680 _d22590680 |
||